Bryn Mawr Capital Management, LLC - AKARI THERAPEUTICS PLC ownership

AKARI THERAPEUTICS PLC's ticker is AKTX and the CUSIP is 00972G108. A total of 12 filers reported holding AKARI THERAPEUTICS PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Bryn Mawr Capital Management, LLC ownership history of AKARI THERAPEUTICS PLC
ValueSharesWeighting
Q2 2023$17,000
-6.4%
100,0000.0%0.00%0.0%
Q1 2023$18,170
-61.3%
100,0000.0%0.00%
-60.0%
Q4 2022$46,990
-25.4%
100,0000.0%0.01%
-77.3%
Q3 2022$63,000
-37.0%
100,0000.0%0.02%
-33.3%
Q2 2022$100,000
-16.7%
100,0000.0%0.03%0.0%
Q1 2022$120,000
-20.0%
100,0000.0%0.03%
-42.1%
Q4 2021$150,000100,0000.06%
Other shareholders
AKARI THERAPEUTICS PLC shareholders Q1 2022
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 7,941,867$1,443,0371.26%
Omnia Family Wealth, LLC 782,372$142,1570.11%
NEA Management Company, LLC 452,167$82,1590.01%
Hikari Power Ltd 130,821$240.00%
Bryn Mawr Capital Management, LLC 100,000$18,1700.00%
GEODE CAPITAL MANAGEMENT, LLC 30,264$5,4950.00%
MILLENNIUM MANAGEMENT LLC 261,192$470.00%
Renaissance Technologies 283,550$520.00%
LPL Financial LLC 134,453$24,4300.00%
JPMORGAN CHASE & CO 237$00.00%
View complete list of AKARI THERAPEUTICS PLC shareholders